The Losartan Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The losartan market has been expanding steadily over recent years. The market was valued at $1.44 billion in 2024 and is projected to reach $1.50 billion in 2025, growing at a compound annual growth rate (CAGR) of 4.6%.
The Losartan Global Market is expected to reach a value of $1.79 billion in 2029, growing at a compound annual growth rate (CAGR) of 4.6%.
Download Your Free Sample of the 2025 Losartan Market Report and Uncover Key Trends Now!The key drivers in the losartan market are:
• Increasing demand for cost-effective antihypertensive drugs
• Growing emphasis on preventive healthcare
• Rising prevalence of lifestyle-related disorders
• Expanding healthcare access in emerging markets
The losartan market covered in this report is segmented –
1) By Dosage: Tablet, Powder, Suspension
2) By Source: Contract Manufacturing Organizations, In-House
3) By Distribution Channel: Online, Offline
4) By Application: Hypertension, Stroke, Diabetic Nephropathy, Other Applications
5) By End-User: Adult, Pediatric
The key trends in the losartan market are:
• Advancements in drug delivery systems are significantly influencing the market.
• There's a growing trend towards development of fixed-dose combination therapies.
• Innovation in formulation technologies is becoming a key market trend.
• Trends towards advanced manufacturing processes and personalized medicine approaches are shaping the future.
Major players in the losartan market are:
• Viatris Inc.
• Teva Pharmaceutical Industries Ltd
• Intas Pharmaceuticals Ltd.
• Sun Pharmaceutical Industries Ltd.
• Apotex Inc.
• Aurobindo Pharma Ltd.
• Dr. Reddy's Laboratories Ltd.
• Cipla Ltd.
• Cadila Pharmaceuticals Ltd.
• Lupin Ltd.
• Zydus Lifesciences Ltd.
• Torrent Pharmaceuticals Ltd.
• Alembic Pharmaceuticals Ltd.
• Vasudha Pharma Chem Ltd.
• Unichem Laboratories Ltd.
• Global Pharma Tek
• Manus Aktteva Biopharma LLP
• Emcure Pharmaceuticals Ltd.
• Wellona Pharma
• JPM Pharma & Chemicals Pvt. Ltd.
North America was the largest region in the losartan market in 2024